Cargando…

Harnessing RNA sequencing for global, unbiased evaluation of two new adjuvants for dendritic-cell immunotherapy

Effective stimulation of immune cells is crucial for the success of cancer immunotherapies. Current approaches to evaluate the efficiency of stimuli are mainly defined by known flow cytometry-based cell activation or cell maturation markers. This method however does not give a complete overview of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mathan, Till S.M., Textor, Johannes, Sköld, Annette E., Reinieren-Beeren, Inge, van Oorschot, Tom, Brüning, Mareke, Figdor, Carl G., Buschow, Sonja I., Bakdash, Ghaith, de Vries, I. Jolanda M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386730/ https://www.ncbi.nlm.nih.gov/pubmed/28186996 http://dx.doi.org/10.18632/oncotarget.15190

Ejemplares similares

Proteome Based Construction of the Lymphocyte Function-Associated Antigen 1 (LFA-1) Interactome in Human Dendritic Cells
por: Eich, Christina, et al.
Publicado: (2016)

Human Plasmacytoid Dendritic Cells: From Molecules to Intercellular Communication Network
por: Mathan, Till S. M., et al.
Publicado: (2013)

A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets
por: Sittig, Simone P., et al.
Publicado: (2016)

N-glycan mediated adhesion strengthening during pathogen-receptor binding revealed by cell-cell force spectroscopy
por: te Riet, Joost, et al.
Publicado: (2017)

The nature of activatory and tolerogenic dendritic cell-derived signal II
por: Bakdash, Ghaith, et al.
Publicado: (2013)

Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells
por: Sköld, Annette E., et al.
Publicado: (2018)

Harnessing human plasmacytoid dendritic cells as professional APCs
por: Tel, Jurjen, et al.
Publicado: (2012)

Proteomics of Human Dendritic Cell Subsets Reveals Subset-Specific Surface Markers and Differential Inflammasome Function
por: Worah, Kuntal, et al.
Publicado: (2016)

Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein
por: Buschow, Sonja I., et al.
Publicado: (2017)

Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets
por: Sköld, Annette E., et al.
Publicado: (2015)

The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues
por: Tel, Jurjen, et al.
Publicado: (2011)

Single-cell analysis reveals that stochasticity and paracrine signaling control interferon-alpha production by plasmacytoid dendritic cells
por: Wimmers, Florian, et al.
Publicado: (2018)

Innate Lymphoid Cells in Tumor Immunity
por: van Beek, Jasper J. P., et al.
Publicado: (2016)

Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets
por: Wimmers, Florian, et al.
Publicado: (2014)

BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?
por: van Ee, Thomas J., et al.
Publicado: (2018)

Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity
por: van Beek, Jasper J. P., et al.
Publicado: (2016)

Human Dendritic Cell Subsets Undergo Distinct Metabolic Reprogramming for Immune Response
por: Basit, Farhan, et al.
Publicado: (2018)

Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3‐dioxygenase 1 with functional effects on T cell priming
por: Sittig, Simone P., et al.
Publicado: (2021)

Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death
por: Di Blasio, Stefania, et al.
Publicado: (2016)

Interleukin-4 Alters Early Phagosome Phenotype by Modulating Class I PI3K Dependent Lipid Remodeling and Protein Recruitment
por: de Keijzer, Sandra, et al.
Publicado: (2011)

A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery
por: Creemers, Jeroen H A, et al.
Publicado: (2021)

Adjuvant dendritic cell vaccination in high-risk uveal melanoma patients
por: Bol, Kalijn, et al.
Publicado: (2015)

Changes in membrane sphingolipid composition modulate dynamics and adhesion of integrin nanoclusters
por: Eich, Christina, et al.
Publicado: (2016)

In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome
por: Creemers, Jeroen H. A., et al.
Publicado: (2023)

The Modular Nature of Dendritic Cell Responses to Commensal and Pathogenic Fungi
por: Rizzetto, Lisa, et al.
Publicado: (2012)

T cell landscape within primary melanoma as a biomarker of survival after cancer vaccination in patients with metastatic disease
por: Vasaturo, Angela, et al.
Publicado: (2015)

Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer
por: Bödder, Johanna, et al.
Publicado: (2021)

Paired primary and metastatic lesions of patients with ipilimumab-treated melanoma: high variation in lymphocyte infiltration and HLA-ABC expression whereas tumor mutational load is similar and correlates with clinical outcome
por: Gorris, Mark A J, et al.
Publicado: (2022)

Naturally circulating dendritic cells to vaccinate cancer patients
por: Bol, Kalijn F., et al.
Publicado: (2013)

Attacking Tumors From All Sides: Personalized Multiplex Vaccines to Tackle Intratumor Heterogeneity
por: Fennemann, Felix L., et al.
Publicado: (2019)

Adjuvants of Immunity : Harnessing Innate Immunity to Promote Adaptive Immunity
por: Bendelac, Albert, et al.
Publicado: (2002)

Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer
por: Westdorp, Harm, et al.
Publicado: (2019)

Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients
por: Boudewijns, Steve, et al.
Publicado: (2016)

CD4(+) T Cells in Chronic Hepatitis B and T Cell-Directed Immunotherapy
por: Buschow, Sonja I., et al.
Publicado: (2021)

Harnessing the Power of Mast Cells in unconventional Immunotherapy Strategies and Vaccine Adjuvants
por: Willows, Steven, et al.
Publicado: (2020)

Unbiased estimators and their applications
por: Voinov, V G, et al.
Publicado: (1993)

Unbiased pangenome graphs
por: Garrison, Erik, et al.
Publicado: (2022)

Opportunities for Conventional and In Situ Cancer Vaccine Strategies and Combination with Immunotherapy for Gastrointestinal Cancers, A Review
por: Bouzid, Rachid, et al.
Publicado: (2020)

Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination
por: van der Woude, Lieke L, et al.
Publicado: (2022)

Unbiased stereology : three-dimensional measurement in microscopy /
por: Howard, Vyvyan
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_npf357v6ah3lrrheqvictenca4